CNS Pharmaceuticals, Inc. is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company identifies and advances therapeutic opportunities that address significant unmet medical needs. CNS Pharmaceuticals operates in the biopharmaceutical sector, targeting patients with conditions in neurology and oncology. It seeks to create long-term value for patients and shareholders through its pipeline of therapeutic candidates.
